• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

iScience . Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron

tetano

Editor, Senior Moderator
iScience


. 2022 Oct 10;105316.
doi: 10.1016/j.isci.2022.105316. Online ahead of print.
Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron


Mehdi Benlarbi[SUP] 1 2 3 [/SUP], Geneviève Laroche[SUP] 1 2 3 [/SUP], Corby Fink[SUP] 4 5 [/SUP], Kathy Fu[SUP] 1 2 3 [/SUP], Rory P Mulloy[SUP] 1 2 3 [/SUP], Alexandra Phan[SUP] 1 2 3 [/SUP], Ardeshir Ariana[SUP] 1 2 3 [/SUP], Corina M Stewart[SUP] 1 2 3 [/SUP], Jérémie Prévost[SUP] 6 7 [/SUP], Guillaume Beaudoin-Bussières[SUP] 6 7 [/SUP], Redaet Daniel[SUP] 1 2 3 [/SUP], Yuxia Bo[SUP] 1 2 3 [/SUP], Omar El Ferri[SUP] 1 2 3 [/SUP], Julien Yockell-Lelièvre[SUP] 1 2 8 9 [/SUP], William L Stanford[SUP] 1 2 8 9 [/SUP], Patrick M Giguère[SUP] 1 [/SUP], Samira Mubareka[SUP] 10 11 [/SUP], Andrés Finzi[SUP] 6 7 [/SUP], Gregory A Dekaban[SUP] 4 5 [/SUP], Jimmy D Dikeakos[SUP] 4 5 [/SUP], Marceline Côté[SUP] 1 2 3 [/SUP]



Affiliations

Abstract

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike glycoprotein (S) binds to angiotensin-converting enzyme 2 (ACE2) to mediate membrane fusion via two distinct pathways: 1) a surface, serine protease-dependent or 2) an endosomal, cysteine protease-dependent pathway. In this study, we found that SARS-CoV-2 S has a wider protease usage and can also be activated by TMPRSS13 and matrix metalloproteinases (MMPs). We found that MMP-2 and MMP-9 played roles in SARS-CoV-2 S cell-cell fusion and TMPRSS2- and cathepsin-independent viral entry in cells expressing high MMP levels. MMP-dependent viral entry required cleavage at the S1/S2 junction in viral producer cells, and differential processing of variants of concern S dictated its usage; the efficiently processed Delta S preferred metalloproteinase-dependent entry when available, and less processed Omicron S was unable to us metalloproteinases for entry. As MMP-2/9 are released during inflammation, they may play roles in S-mediated cytopathic effects, tropism, and disease outcome.

Keywords: SARS-CoV-2; Spike glycoprotein; membrane fusion; metalloproteinases; variants of concern; viral entry.
 
Back
Top Bottom